| | | Term birth (n = 52) | Delivered 28–37 weeks (n = 9) | Delivered <28 weeks (n = 12) | | Artificial abortion (n = 134) | Embryo arrest (n = 43) | Total (n = 250) |
| Clinical information | Age (y) | 31 (27.5, 33.5) | 32 (30, 35) | 31.5 (29.5, 33.5) | 0.116 | 33 (30, 37) | 34 (30, 37) | 33 (29.75, 36) | G | 2 (1, 2) | 2 (1, 2) | 2 (1, 2.5) | 0.634 | 2 (2, 3) | 2 (1,3) | 2 (1, 3) | P | 0 (0,1) | 1 (0,1) | 1 (0,1) | 0.825 | 1 (1, 1) | 0.5 (0, 1) | 1 (0, 1) | Systemic comorbidities | 6 (2.4%) | 0 (0%) | 2 (0.8%) | 0.466 | 0 (0%) | 0 (0%) | 8 (3.2%) | Gynecological comorbidities | 6 (2.4%) | 0 (0%) | 5 (2.0%) | 0.013 | 8 (3.2%) | 1 (0.4%) | 20 (8%) | Medication history | 7 (2.8%) | 1 (0.4%) | 2 (0.8%) | 0.931 | 9 (3.6%) | 6 (2.4%) | 25 (10%) | Pregnancy complications | 6 (2.4%) | 2 (0.8%) | 0 (0%) | 0.264 | 1 (0.4%) | 0 (0%) | 9 (3.6%) | Colporrhagia | 41 (16.4%) | 7 (2.8%) | 8 (3.2%) | 0.665 | 34 (13.6%) | 15 (6%) | 105 (42%) | Ultrasonic | 1 (0.4%) | 2 (0.8%) | 2 (0.8%) | 0.028 | 13 (5.2%) | 4 (1.6%) | 22 (8.8%) | Leucorrhea | 15 (6%) | 1 (0.4%) | 3 (1.2%) | 0.532 | 42 (16.8%) | 9 (3.6%) | 69 (27.6%) | Blood routine | 17 (6.8%) | 2 (0.8%) | 4 (1.6%) | 0.814 | 62 (24.8%) | 22 (8.8%) | 107 (42.8%) | Colposcopy | 13 (5.2%) | 3 (1.2%) | 3 (1.2%) | 0.867 | 0 (0%) | 0 (0%) | 19 (7.6%) | Diagnosis information | Cervical cytology | 4 (1.6%) | 2 (0.8%) | 3 (1.2%) | 0.163 | 3 (1.2%) | 0 (0%) | 12 (4.8%) | Discovery by accident | 4 (1.6%) | 0 (0%) | 1 (0.4%) | 0.683 | 82 (32.8%) | 23 (9.2%) | 110 (44%) | Discovery week (w) | 11.5 (9, 15.5) | 16 (9, 16) | 8 (5.5, 11) | 0.033 | 6 (6, 7) | 8 (7.75, 9) | 7 (6, 9) | The first trimester | 21 (8.4%) | 4 (1.6%) | 8 (3.2%) | | 133 (53.2%) | 42 (16.8%) | 208 (83.2%) | The second trimester | 30 (12%) | 4 (1.6%) | 4 (1.6%) | | 1 (0.4%) | 1 (0.4%) | 40 (16%) | The third trimester | 1 (0.4%) | 1 (0.4%) | 0 (0%) | | 0 (0%) | 0 (0%) | 2 (0.8%) | Histopathological features | No. of polyp. | 1 (1,1) | 1 (1,1) | 1 (1,1) | 0.817 | 1 (1,1) | 1 (1,1) | 1 (1,1) | Diameter of polyp | 2 (1.5, 3) | 1.5 (1, 2.5) | 2.5 (1.25, 4) | 0.574 | 1 (0.5, 1.5) | 0.5 (0.5, 1) | 1 (0.5, 2) | Endometrial polyp | 15 (6%) | 1 (0.4%) | 3 (1.2%) | 0.532 | 42 (16.8%) | 11 (4.4%) | 72 (28.8%) | Endometrial fragment | 37 (14.8%) | 8 (3.2%) | 9 (3.6%) | 0.532 | 92 (36.8%) | 32 (12.8%) | 178 (71.2%) | Inflammation | 52 (20.8%) | 9 (3.6%) | 12 (4.8%) | NA | 131 (52.4%) | 42 (16.8%) | 246 (98.4%) | Hemorrhage | 15 (6%) | 3 (1.2%) | 3 (1.2%) | 0.916 | 31 (12.4%) | 5 (2.0%) | 57 (22.8%) | Erosion | 49 (19.6%) | 9 (3.6%) | 11 (4.4%) | 0.698 | 119 (47.6%) | 37 (14.8%) | 225 (90%) | Necrosis | 20 (8%) | 4 (1.6%) | 3 (1.2%) | 0.606 | 46 (18.4%) | 12 (4.8%) | 85 (34%) | Thrombus | 2 (0.8%) | 2 (0.8%) | 3 (1.2%) | 0.031 | 32 (12.8%) | 3 (1.2%) | 42 (16.8%) | Original diagnosis | | | | | | | | Decidua | 23 (9.2%) | 1 (0.4%) | 5 (2.0%) | 0.171 | 43 (17.2%) | 20 (8%) | 92 (36.8%) | Endometrial polyp | 23 (9.2%) | 7 (2.8%) | 4 (1.6%) | 0.106 | 59 (23.6%) | 13 (5.2%) | 106 (42.4%) | Endocervical polyp | 6 (2.4%) | 1 (0.4%) | 3 (1.2%) | 0.460 | 32 (12.8%) | 10 (4%) | 52 (20.8%) |
|
|